Single Use Bioreactor Market To Reach USD 13,595.9 Million by 2030 | P&S Intelligence

The single-use bioreactors market will grow at a 18.8% CAGR in the years to come, and will reach to a value of USD 13,595.9 million by 2030. The growth of the industry is powered by the increasing prevalence of infectious and chronic diseases.

There has been a significant increase in the number of infectious diseases worldwide. The COVID-19 pandemic has led to the rapid adoption of advanced technologies by life sciences and biopharmaceutical firms to produce vaccines quickly and on a large scale.

Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/single-use-bioreactors-market/report-sample

This has brought about a growing demand for single-use systems, which are flexible and modular, allowing for local manufacturing facilities in emerging nations that lack investments. These systems are mainly utilized in the production of viral vaccines.

To better understand the COVID-19 virus's behavior in humans, some manufacturers are using bioreactors to cultivate suitable host cells. Additionally, several companies have entered in collaborations to enhance their market positions.

Startups and small to medium-sized enterprises are increasingly using bioreactors due to the high costs involved in setting up traditional biomanufacturing facilities. These companies produce fewer batches annually and find stainless steel facilities expensive.

As a result, they are adopting single-use systems that require less capital investment and eliminate the need for validation, sterilization, cleaning, and changeover processes.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=single-use-bioreactors-market

The system category dominates the market, with 55% of the revenue share in 2022. This is due to its widespread use in biopharmaceutical manufacturing facilities that require high product yields. These systems are cost-effective, versatile, and capable of large-scale production, meeting the increasing demand for biotherapeutics like antibodies, hormones, vaccines, and enzymes.

Top Companies Providing Single-Use Bioreactors Are:
• Sartorius AG
• Thermo Fisher Scientific Inc.
• Getinge AB
• Merck KGaA
• Eppendorf SE
• PBS Biotech Inc.
• Distek Inc.
• ABEC Inc.
• G&G Technologies Inc.
• Solida Biotech GmBH

North America dominates the single-use bioreactors market due to factors like the high prevalence of chronic diseases, presence of top players, advanced healthcare facilities, technological advancements and strong research and development initiatives.

Within North America, the U.S. plays a significant role, driven by the adoption of innovative technologies, public awareness regarding disease prevention, government support, and advanced healthcare infrastructure.

The vaccines category had the largest revenue share in 2022 due to the increase in infectious diseases. The demand for mass production of vaccines for prevention and treatment purposes has increased. The COVID-19 pandemic further accelerated vaccine manufacturing, leading to the adoption of single-use bioreactors.

Browse full report at: https://www.psmarketresearch.com/market-analysis/single-use-bioreactors-market

Lab-scale production is leading the industry. This is due to the fact that the biopharma industry requires the frequent use of bioreactors for various preclinical and clinical research purposes.

Moreover, the increasing acceptance and progressions in single-use technologies will all boost the expansion of the industry, a great deal in the future.

It is because of the increasing research and development activities in the medical industry, that the demand for single-use bioreactors will continue to rise in the years to come.

Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarefuturetrends.blogspot.com

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

This release was published on openPR.